Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of <i>CRNDE</i> as a Poor Survival Prognosis Biomarker in Glioblastoma

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of <i>CRNDE</i> as a Poor Survival Prognosis Biomarker in Glioblastoma

Glioblastoma is the most common and malignant brain malignancy worldwide, with a 10-year survival of only 0.7%. Aggressive multimodal treatment is not enough to increase life expectancy and provide good quality of life for glioblastoma patients. In addition, despite decades of research, there are no...

Full description

Bibliographic Details
Main Authors: Maxim Sorokin, Mikhail Raevskiy, Alja Zottel, Neja Šamec, Marija Skoblar Vidmar, Alenka Matjašič, Andrej Zupan, Jernej Mlakar, Maria Suntsova, Denis V. Kuzmin, Anton Buzdin, Ivana Jovčevska
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
glioblastoma
noncoding RNA
<i>CRNDE</i>
RNA sequencing
long-term survival
Online Access:https://www.mdpi.com/2072-6694/13/14/3419

Internet

https://www.mdpi.com/2072-6694/13/14/3419

Similar Items